All Stories

  1. Anticancer Drug Combinations: Different Strategies Used in the Clinic
  2. Cancer Bioinformatics, New Chapter of Personalized Medicine
  3. Pulmonary nodules, knowledge renovation and comprehensive studies
  4. Personalized Oncology: Scientific and Technical Approaches
  5. Advances in Cancer Therapeutics and Genomics for Improved Patient Outcomes
  6. Magnetic water and clinical cancer chemotherapy
  7. Human suicide, clinical treatment overview
  8. Sexually transmitted disease diagnosis and treatments, risk factors from beyond
  9. Human suicide, risk factors and new perspective
  10. Suicide study, new approaches
  11. Human suicide, molecular framework
  12. COVID-19 knowledge and therapeutics, past, present and future
  13. Artificial intelligence for advancing nursery service
  14. Treatment improvements by pediatric Theranostics
  15. COVID-19 conception advances, epidemics, pathology and therapeutics
  16. Withdrawn: Professor Bin Xu, A Legendary Pharmacologist in People’s Republic of China
  17. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  18. Anticancer Drug Development, Pharmaceutical Progress
  19. Human Suicide, Biomedical Knowledge Advances
  20. Type 2 Diabetes Treatments in Countries of Different Economic Status
  21. Human suicide, biomedical knowledge and therapeutic advances
  22. Human Suicide, an Overview of Management Strategies
  23. COVID-19 Research, Public Health and Biomedical Basis
  24. Human Suicide, Management Landscape
  25. Anticancer Drug Development: Evaluative Architecture
  26. COVID-19 Study: A New Principle Discovery
  27. COVID-19 Study, Diagnostic and Therapeutic Transition
  28. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  29. Nursery services advances, global campaign
  30. Different approaches to bone transplantation surgery
  31. Bone Metastasis Diagnosis, Blood Biomarker Detections
  32. Anti-metastatic drug development, overview and perspectives
  33. Educational Perspectives for Nursery
  34. Is Tau Molecule Regarded as a Risk Factor for Human Suicide?
  35. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  36. Suicide Curative Treatment Study and Drug Development
  37. Pulmonary nodules, is there any pathogenesis evidence?
  38. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  39. Pulmonary nodules, surgery or other medication
  40. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  41. Pulmonary Nodules, Surgery or Other Medication
  42. Anti-Metastatic Drug Developments, Utility of More Animal Models
  43. Several approaches for anticancer drug development progress
  44. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  45. COVID-19 infection for metabolic abnormal human beings
  46. Fundamental knowledge for nurses 
  47. Nursery promotion, education and system updating
  48. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  49. Covid-19 Study, Pathology and Therapeutics
  50. Acupuncture for Bone Disease Treatments, Modern Approaches
  51. Cancer Bone Metastasis, Experimental Study
  52. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  53. Osteoporosis Targeting, Possible Breakthroughs
  54. Neuropsychiatric insights for human suicide
  55. Bone Cancer and Metastasis Trials, Drug Treatment
  56. Neurobiology for human suicide
  57. Bone Disease Treatment Study, Major Pathways
  58. Pathology Study for Human Suicide
  59. Nursery activity and quality, chemistry between doctors and nurses
  60. Nursery education, narrow-range or wide-range
  61. Anticancer drug development, challenge and dilemma
  62. Life Origin on Earth, Knowledge Development
  63. HIV/AIDS treatment, therapeutic strategy break throughs
  64. Nursery education for diabetes
  65. Suicide Risks and Prevention, Neuropathogenic Study
  66. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  67. General information for nursery
  68. Historical analysis of suicide
  69. Drug sensitivity testing, a unique drug selection strategy
  70. Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs
  71. Medical treatments for incurable diseases, palliative therapy
  72. Life Origin on Earth, Biochemical Approaches
  73. Nursery training, from technique details in schools into medical knowledge education in nursery career
  74. Herbal medicine in new era
  75. Nursery service, quality promotion
  76. Anti-Metastatic Drug Developments, Biomedical Mechanisms and Therapeutic Categorization
  77. Patient’s care and nursery in different diseases
  78. Ebola Therapeutic Study and Future Directions
  79. New HIV/AIDS Therapeutics
  80. Nursery Service in Modern Days
  81. Nursery Education, Capability and Service Promotion
  82. Nursery Science and Conventions
  83. Cancer Bioinformatics in Cancer Therapy
  84. Individualized Cancer Therapy
  85. Human Suicide Risk and Treatment Study
  86. Type 2 Diabetes Treatment and Drug Development Study
  87. Hypotheses for Life Origin on Earth, Comparison and Validation
  88. Type 2 Diabetes Study, Introduction and Perspective
  89. Type 2 Diabetes Mellitus Study, A Process of Enigma unraveling
  90. Anthocyanins and its biological & therapeutic characters
  91. Diabetes Prevention and Treatments, a Specific Topic for Modern Medicines
  92. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  93. Pathology and treatments of obesity
  94. Obesity, Risks and Managements
  95. Keep up the pace of drug development evolution and expenditure
  96. An Overview of Obesity
  97. General Topics in the Field of Personalized Cancer Therapy
  98. Human Suicide Risk Study and Treatment: A Mathematical Approach
  99. Anti-Metastatic Drug Developments: Work Out towards New Direction
  100. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  101. Drug Combination in Clinical Cancer Treatments
  102. General outlook for individualized cancer therapy
  103. Ebola origin and treatment
  104. Different Disciplines in the Field of Suicide Study
  105. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  106. HAART in HIV/AIDS Treatments
  107. Anticancer Drug Development, System Updating and Global Participations
  108. Life Origin on Earth, What is the Right Answer?
  109. Life Origin on Earth, What is the Right Answer?
  110. Anticancer Drug Development, Getting out from Bottleneck
  111. Anticancer Drug Development, Getting out from Bottleneck
  112. Human suicide study, major disciplines and treatment outcomes
  113. Anticancer drug development
  114. HIV in Human Genomes and Therapeutics
  115. HIV Biotherapy and Natural Chemotherapeutic Agents
  116. Anticancer Drug Combinations, How Far We can Go Through?
  117. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  118. Life Origin on Earth, Insights among Different Arguments
  119. Genetics in Suicide Treatments, Modern Diagnosis Establishments
  120. Diabetes Preventions and Treatments, a Specific Topic for Modern Medicines
  121. Anticancer Drug Development, Breakthroughs are Waiting
  122. Cancer metastasis treatment, a key drawbacks
  123. The suicide treatment, a new model
  124. HIV Vaccine for Prevention and Cure, A Mission Possible
  125. Zika Therapy
  126. HIV vaccine
  127. Discover Natural Chemical Drugs in Modern Medicines
  128. Mathematics in biomedical science
  129. The origin of HIV
  130. Human suicide study
  131. Mathematics or Physics-Majored Students on the Biomedical Fields, Insiders or Outsiders?
  132. Pharmacogenetics of Cancer Therapy
  133. Anticancer Drug Sensitivity Testing
  134. New Perspectives of HIV/AIDS Therapy Study
  135. Antidepressant treatment study
  136. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  137. Assistant cancer treatments in the clinic
  138. Drug sensitivity testing in clinical cancer treatments
  139. Anticancer drug combination in the clinic
  140. Anticancer drug pharmacogenomics in cancer chemotherapy
  141. Cost-effectiveness for personalized cancer therapy
  142. Conclusion
  143. Introduction
  144. Discussion
  145. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  146. Anti-diabetic treatments
  147. Anticancer Drug Combinational Study
  148. The Origins of HIV
  149. Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or Fibrinolytical Agents
  150. Anticancer Drug Combinations, A Big Momentum is Needed
  151. Anticancer Drug Development, a Matter of Money or a Matter of Idea?
  152. Future Perspectives for Controlling Ebola Epidemics
  153. Ebola Origin and Therapies
  154. Cancer Bioinformatics, its Impacts on Cancer Therapy
  155. Copyright
  156. List of figures and tables
  157. Anti-diabetic treatments, patho-therapeutic relation
  158. Origin of Ebola, hypothesis
  159. Personalized Cancer Therapy: A Perspective
  160. Rethink Of Diabetes Treatment and Drug Development
  161. Pharmacogenomics in human suicide prediction and treatments
  162. Cancer metastasis treatment study and drug developments
  163. Challenge for HIV/AIDS therapy
  164. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  165. Drug Combinations in Cancer Treatments
  166. New Insights into Individualized Antimetastatic Therapy
  167. Anticancer drugs on serum sialic acid level in mice bearing LLC
  168. Drug Combinations in Cancer Treatments
  169. Genetics in Neural Toxicity of Drugs
  170. Avian flu, pathogenesis and therapeutic study
  171. First Genetic Information Replication in Life Origin on Earth
  172. Origins of Life, A New Cooperative Model
  173. Cancer Metastases and Clinical Therapies
  174. Origins of Life, RNA world or alternative RNA world
  175. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  176. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  177. Antimetastatic Therapies according to Metastatic Cascade
  178. Genetics in antidepressant-induced suicide
  179. Pathology of Drug-induced mania & suicide
  180. Influenza treatment
  181. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  182. Individualized cancer chemotherapy
  183. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  184. The Hypotheses for the Pathogeny of Drug-Induced Mania and Suicide
  185. The Relationship between Tumor Sialic Acids and Neoplasm Metastasis and as a Drug Target
  186. Genomic study of antidepressant-induced suicide
  187. Aberrant sialylation in tumor cells
  188. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  189. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  190. Neural toxicity of drugs
  191. Anticancer activity and mechanisms of Bisdioxopiperazines
  192. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  193. 14C-probimane in the mice bearing LLC
  194. Unsatisfactory design of human AIDS genome research
  195. Antidepressant in Cancer Treatment
  196. AIDS and human genome studies, from a hypothesis to systematic approaches
  197. Antidepressants in Human suicide
  198. Mathematical model in therapeutic risk prediction
  199. Fibrinogen in neoplasm metastasis
  200. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  201. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  202. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  203. Individualized cancer chemotheray
  204. Anti-proliferative and chromosome segregation by probimane and MST-16
  205. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  206. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  207. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  208. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  209. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  210. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  211. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  212. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  213. Journal of Clinical and Medical Reviews